Princeton Capital Management Inc’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Princeton Capital Management Inc’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-18,486	Closed	-$853K	–	73
2016 Q3	$853K	Buy	18,486 +34	+0.2%	+$1.92K	0.56%	47
2016 Q2	$942K	Buy	18,452 +8,890	+93%	+$442K	0.65%	40
2016 Q1	$404K	Buy	9,562 +12	+0.1%	+$611	0.28%	53
2015 Q4	$750K	Sell	9,550 -175	-2%	-$10.1K	0.53%	44
2015 Q3	$394K	Buy	9,725 +2,625	+37%	+$139K	0.24%	53
2015 Q2	$370K	Buy	+7,100	New	+$353K	0.2%	55

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Princeton Capital Management Inc's ISEE Position: Q4 2016 in Review

Princeton Capital Management Inc sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 18,486 shares — an estimated $853K sold.

Princeton Capital Management Inc first reported a position in ISEE in Q2 2015 and held it in 6 quarters. The position peaked at $942K in Q2 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

Princeton Capital Management Inc reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Princeton Capital Management Inc sold 18,486 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $853K.
Princeton Capital Management Inc first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 6 quarters.
Princeton Capital Management Inc's IVERIC bio, Inc. Common Stock position peaked at $942K in Q2 2016.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Princeton Capital Management Inc's 13F filing for Q4 2016, filed 2 Feb 2017.